Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-30 @ 10:05 AM
Study NCT ID:
NCT04816669
Status:
COMPLETED
Last Update Posted:
2022-12-23
First Post:
2021-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
Sponsor:
BioNTech SE
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-24
First Submit QC Date:
None
Study First Post Date:
2021-03-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-11-30
Results First Submit QC Date:
None
Results First Post Date:
2022-12-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-30
Last Update Post Date:
2022-12-23
Last Update Post Date Type:
ACTUAL